Case and UH receive state support to launch commercialization fund

The Ohio Third Frontier has invested $3 million in an initiative from Case Western Reserve University and University Hospitals Case Medical Center designed to bring research and treatment breakthroughs to market.

In addition to the state support, Case Western Reserve will invest $2 million and UH Case Medical Center $1 million to the Case Technology and University Hospitals Ventures (CTUHV) Fund.  The pre-seed fund will aim to help advance commercialization of discoveries that include medical technology related to imaging, medical and surgical devices, regenerative medicine, healthcare software, advanced materials, and energy.

“The CTUHV Fund is predicated on the success of Case Technology Ventures, Northeast Ohio’s first seed fund of this kind,” said Joe Jankowski, assistant vice president for Technology Transfer at Case Western Reserve. “Created in 2003, the CTV established myriad active companies employing 120 full-time employees in the region, and which leveraged investments of more than $91 million—a 53-to-1 ratio compared to the $1.7 million in pre-seed money.”

Those companies include Arteroiocyte, which has received U.S. and foreign approval for five stem-cell and tissue-engineering-based products. Also CardioInsight, which has developed 3D whole-heart electroanatomy mapping technology that assists doctors in diagnosing heart arrhythmias.

Stephen Behm, director of technology management at UH Case Medical Center, said the fund will capitalize on the healthcare expertise and patient care found at the medical center.

“UH Case Medical Center is a world leading research-oriented healthcare institution that has a strong history of commercializing research,” Behm said. “Our physicians are on the leading edge of developing new techniques and therapies in the pursuit of our mission: ‘To Heal. To Teach. To Discover.’ and this fund will help bring some of these discoveries to market for the benefit of patients.”

The university and the hospital combined their efforts to enhance their chances for securing a state grant. They focused on pre-seed funding because that’s traditionally been the greatest need.

The CTUHV Fund aims to invest in 12 new companies with half achieving follow-on Series-A financing within 2 years of receiving pre-seed money, creating an average of 20 employees per company and leveraging capitalization at a rate of better than 15 to 1.

The new fund will invest in start-up companies and firms recruited to Ohio to support the venture. Such entities may include those with strong ties to the institutions and/or have forged a formal relationship with the Ohio Third Frontier Entrepreneur Signature Program (ESP) and the collaborators.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

University of Toledo Medical Center’s new $36M simulator makes training nearly real | Toledo Blade, April 23, 2014

Aerpio Therapeutics closes $22M financing led by OrbiMed (pdf) | Aerpio Therapeutics, April 23, 2014

CTI Clinical Trial & Consulting Services continues to grow with promotions and new hires | Cincinnati.com, April 22, 2014

Austen BioInnovation Institute in Akron presenting two FDA events in one day, April 29 | Austen BioInnovation Institute in Akron, April 22, 2014

OSU collaboration with California’s Oakbio awarded $500k from Canada’s CCEMC to develop biofuels | PR Newswire, April 22, 2014

OSU students’ non-polluting KAir battery wins $100K from US DOE | Columbus Business First, April 22, 2014

The Medical Imaging Technology Partnering Forum part of Cleveland’s medical imaging strength | Cleveland.com, April 22, 2014

Akebia Therapeutics stock rose 55% last week, from below $17 to above $26 | Cincinnati Business Courier, April 21, 2014

The Austen BioInnovation Institute in Akron working with Nottingham Spirk, a Cleveland-based design firm | Akron Beacon Journal, April 21, 2014

CincyTech discusses recent funding for Assurex Health & Sirrus (Bioformix) | Cincinnati Business Courier, April 21, 2014

Akron Children’s joins with Cincinnati Children’s to offer access to new cancer treatments | Akron Beacon Journal, April 20, 2014

OSU Biomedical Engineering students and OncoFilter partners Kinshuk Mitra and Brett Geiger featured on 10TV Columbus | WBNS 10TV Columbus, April 19, 2014

Case Western Reserve University event emphasizes a constellation of research (slideshow) | Cleveland.com, April 19, 2014

Airway Therapeutics granted orphan designation for its product to prevent BPD by European regulatory authority | Cincinnati.com, April 19, 2014

Assurex Health and Sirrus (Bioformix) lead 2014 Q1 funding rounds | Cincinnati.com, April 18, 2014

PhRMA Annual Meeting keynote speakers available on YouTube | PhRMA, April 18, 2014

Alkermes CEO Richard Pops speaks with Xconomy about building the business | Xconomy.com, April 18, 2014

Case Western Reserve University scientists discuss a portable malaria detector (video) | Inside Science TV, April 18, 2014

Ashland University Schar Nursing College starts Doctor of Nursing Program | WMFD Mansfield, April 18, 2014

Kent State Researchers discover new liquid crystal structure | Kent State University, April 17, 2014